drugset / Trial / NCT02943057

Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis

NCT02943057

Phase 4 Completed 25 enrolled Singapore National Eye Centre
NaSingle-groupOpen-labelTreatment

Summary

25 patients who are diagnosed with Cytomegalovirus (CMV) anterior segment infection, either uveitis or endotheliitis, will be started on 2% guttae ganciclovir, 1 drop 5 times a day for 6 weeks. Following 6 weeks of continuous application of 2% guttae ganciclovir, patient will be reviewed at the clinic within 3 hours following the last application of topical ganciclovir and clinical features will be documented for activity assessment. An aqueous sample 0.2ml is drawn. 0.1ml will be sent for RT-PCR for CMV viral load and another 0.1ml will be sent for ganciclovir drug level by HPLC method.

Timeline

Start
2016-10
Primary completion
2024-01
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganciclovir Small molecule 2 % Topical